UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1

CUSIP: 91307CAF9

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
237.25%
Total 13F principal
$228,106,500
Principal change
$0
Total reported market value
$541,079,700
Number of holders
23

Quarterly Holders Quick Answers

What is CUSIP 91307CAF9?
CUSIP 91307CAF9 identifies 91307CAF9 - UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q4 2013

As of 31 Dec 2013, UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 was held by 23 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $228,106,500 in principal (par value) of the bond. The largest 10 bondholders included Whitebox Advisors LLC, CAMDEN ASSET MANAGEMENT L P /CA, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Castle Creek Arbitrage, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BASSO CAPITAL MANAGEMENT L.P., Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS OCONNOR LLC, and BANK OF AMERICA CORP /DE/. This page lists 23 institutional bondholders reporting positions for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.